Neuropeptides, food intake and body weight regulation: A hypothalamic focus

Peptides

Volumn 23, Issue 12, 2002, Pages 2283-2306

  Hillebrand, J J G ^a   De Wied, D ^a   Adan, R A H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Body weight; Energy homeostasis; Food intake; Hypothalamus; Neuropeptides

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN RELEASING FACTOR; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ANOREXIA; APPETITE; BODY WEIGHT; ENERGY; FOOD INTAKE; HOMEOSTASIS; HYPOTHALAMUS; NEUROENDOCRINE SYSTEM; NONHUMAN; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STARVATION; WEIGHT REDUCTION;

BODY WEIGHT; EATING; HOMEOSTASIS; HYPOTHALAMUS; INSULIN; LEPTIN; NEURONS; NEUROPEPTIDES;

EID: 0036953551     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00269-3     Document Type: Review

References (325)

1. Adage T., Scheurink A.J., de Boer S.F., de Vries K., Konsman J.P., Kuipers F.et al. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J. Neurosci. 21:2001;3639-3645.
2. Adan R.A., Gispen W.H. Melanocortins and the brain: from effects via receptors to drug targets. Eur. J. Pharmacol. 405:2000;13-24.
3. Adelman G, Smith BH, editors. Elsevier's enceclopedia of neuroscience. Amsterdam: Elsevier; 1989.
4. Adrian T.E., Allen J.M., Bloom S.R., Ghatei M.A., Rossor M.N., Roberts G.W.et al. Neuropeptide Y distribution in human brain. Nature. 306:1983;584-586.
5. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E.et al. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250-252.
6. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R.et al. Neuropeptide Y distribution in the rat brain. Science. 221:1983;877-879.
7. Ammar A.A., Sederholm F., Saito T.R., Scheurink A.J., Johnson A.E., Sodersten P. NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R1627-R1633.
8. An S., Cutler G., Zhao J.J., Huang S.G., Tian H., Li W.et al. Identification and characterization of a melanin-concentrating hormone receptor. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7576-7581.
9. Arima H., Aguilera G. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors. J. Neuroendocrinol. 12:2000;833-842.
10. Arletti R., Benelli A., Bertolini A. Influence of oxytocin on feeding behavior in the rat. Peptides. 10:1989;89-93.
11. Arnelo U., Permert J., Adrian T.E., Larsson J., Westermark P., Reidelberger R.D. Chronic infusion of islet amyloid polypeptide causes anorexia in rats. Am. J. Physiol. 271:1996;R1654-R1659.
12. Baile C.A., McLaughlin C.L., Della-Fera M.A. Role of cholecystokinin and opioid peptides in control of food intake. Physiol. Rev. 66:1986;172-234.
13. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E.et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24:2000;410-414.
14. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B.et al. Behavioral characterization of neuropeptide Y knockout mice. Brain Res. 868:2000;79-87.
15. Bannon A.W., Seda J., Carmouche M., Richards W.G., Fan W., Jarosinski M., McKinzie A.A., Douglass J. Biological functions of cocaine- and amphetamine-regulated transcript (CART): data with CART peptides and CART knockout mice. Soc. Neurosci. Abstr. 26:2000;2041 (761.10).
16. Baskin D.G., Breininger J.F., Bonigut S., Miller M.A. Leptin binding in the arcuate nucleus is increased during fasting. Brain Res. 828:1999;154-158.
17. Baskin D.G., Wilcox B.J., Figlewicz D.P., Dorsa D.M. Insulin and insulin-like growth factors in the CNS. Trends Neurosci. 11:1988;107-111.
18. Bataille D., Tatemoto K., Gespach C., Jornvall H., Rosselin G., Mutt V. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett. 146:1982;79-86.
19. Beck B., Burlet A., Nicolas J.P., Burlet C. Neurotensin in microdissected brain nuclei and in the pituitary of the lean and obese Zucker rats. Neuropeptides. 13:1989;1-7.
20. Bertolini A., Vergoni W., Gessa G.L., Ferrari W. Induction of sexual excitement by the action of adrenocorticotrophic hormone in brain. Nature. 221:1969;667-669.
21. Billington C.J., Briggs J.E., Grace M., Levine A.S. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 260:1991;R321-R327.
22. Bissette G., Nemeroff C.B., Loosen P.T., Prange A.J. Jr., Lipton M.A. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature. 262:1976;607-609.
23. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L.et al. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization-histochemical characterization. J. Comp. Neurol. 319:1992;218-245.
24. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell. 1:1998;619-625.
25. Blakeman K.H., Holmberg K., Hao J.X., Xu X.J., Kahl U., Lendahl U.et al. Mice over-expressing galanin have elevated heat nociceptive threshold. Neuroreport. 12:2001;423-425.
26. Bradbury M.J., McBurnie M.I., Denton D.A., Lee K.F., Vale W.W. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice [see comments]. Endocrinology. 141:2000;2715-2724.
27. Brann D.W., Wade M.F., Dhandapani K.M., Mahesh V.B., Buchanan C.D. Leptin and reproduction. Steroids. 67:2002;95-104.
28. Bruhn T.O., Sutton S.W., Plotsky P.M., Vale W.W. Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat. Endocrinology. 119:1986;1558-1563.
29. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C.et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2000;2122-2125.
30. Bultman S.J., Michaud E.J., Woychik R.P. Molecular characterization of the mouse agouti locus. Cell. 71:1992;1195-1204.
31. Burcelin R., Brunner H., Seydoux J., Thorensa B., Pedrazzini T. Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice. Peptides. 22:2001;421-427.
32. Burgevin M.C., Loquet I., Quarteronet D., Habert-Ortoli E. Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor. J. Mol. Neurosci. 6:1995;33-41.
33. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J.et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology. 141:2000;3518-3521.
34. Butler P.C., Chou J., Carter W.B., Wang Y.N., Bu B.H., Chang D.et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes. 39:1990;752-756.
35. Cabeza D.V., Kim G.Y., Carr K.D. The melanocortin receptor agonist MTII augments the rewarding effect of amphetamine in ad-libitum-fed and food-restricted rats. Psychopharmacology (Berl.). 161:2002;77-85.
36. Calza L., Forrest D., Vennstrom B., Hokfelt T. Expression of peptides and other neurochemical markers in hypothalamus and olfactory bulb of mice devoid of all known thyroid hormone receptors. Neuroscience. 101:2000;1001-1012.
37. Carvalheira J.B., Siloto R.M., Ignacchitti I., Brenelli S.L., Carvalho C.R., Leite A.et al. Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett. 500:2001;119-124.
38. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
39. Chapman I.M., Goble E.A., Wittert G.A., Morley J.E., Horowitz M. Effect of intravenous glucose and euglycemic insulin infusions on short-term appetite and food intake. Am. J. Physiol. 274:1998;R596-R603.
40. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J.et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84:1996;491-495.
41. Cheung C.C., Hohmann J.G., Clifton D.K., Steiner R.A. Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus. Neuroscience. 103:2001;423-432.
42. Clineschmidt B.V., McGuffin J.C., Bunting P.B. Neurotensin: antinocisponsive action in rodents. Eur. J. Pharmacol. 54:1979;129-139.
43. Corp E.S., Melville L.D., Greenberg D., Gibbs J., Smith G.P. Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors. Am. J. Physiol. 259:1990;R317-R323.
44. Cortright D.N., Goosens K.A., Lesh J.S., Seasholtz A.F. Isolation and characterization of the rat corticotropin-releasing hormone (CRH)-binding protein gene: transcriptional regulation by cyclic adenosine monophosphate and CRH. Endocrinology. 138:1997;2098-2108.
45. Corwin R.L., Corp E.S., Gibbs J., Smith G.P. Decreased behavioral effects of daily intracerebroventricular bombesin. Peptides. 13:1992;1215-1218.
46. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L.et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480-484.
47. Cusin I., Zakrzewska K.E., Boss O., Muzzin P., Giacobino J.P., Ricquier D.et al. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes. 47:1998;1014-1019.
48. D'Alessio D.A., Verchere C.B., Kahn S.E., Hoagland V., Baskin D.G., Palmiter R.D.et al. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes. 43:1994;1457-1461.
49. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T.et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 141:2000;4255-4261.
50. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K.et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 96:1999;748-753.
51. De Wied D. Neuropeptides and behavior. Ned. Tijdschr. Geneeskd. 118:1974;1865-1869.
52. Deacon C.F., Johnsen A.H., Holst J.J. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J. Clin. Endocrinol. Metab. 80:1995;952-957.
53. DeFalco J., Tomishima M., Liu H., Zhao C., Cai X., Marth J.D.et al. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science. 291:2001;2608-2613.
54. Denbow D.M. Centrally and peripherally administered bombesin decreases food intake in turkeys. Peptides. 10:1989;275-279.
55. Desarnaud F., Labbe O., Eggerickx D., Vassart G., Parmentier M. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene. Biochem. J. 299(Pt. 2):1994;367-373.
56. Dobner P.R., Fadel J., Deitemeyer N., Carraway R.E., Deutch A.Y. Neurotensin-deficient mice show altered responses to antipsychotic drugs. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8048-8053.
57. Douglass J., McKinzie A.A., Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15:1995;2471-2481.
58. Dourish C.T., Rycroft W., Iversen S.D. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science. 245:1989;1509-1511.
59. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology. 122:2002;531-544.
60. Drucker D.J., Asa S. Glucagon gene expression in vertebrate brain. J. Biol. Chem. 263:1988;13475-13478.
61. Drucker D.J., Erlich P., Asa S.L., Brubaker P.L. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7911-7916.
62. Edwards C.M., Abbott C.R., Sunter D., Kim M., Dakin C.L., Murphy K.G.et al. Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat. Brain Res. 866:2000;128-134.
63. Edwards C.M., Abusnana S., Sunter D., Murphy K.G., Ghatei M.A., Bloom S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 160:1999;R7-R12.
64. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C.et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron. 23:1999;775-786.
65. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J.et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 402:1998;442-459.
66. Elmquist J.K., Ahima R.S., Elias C.F., Flier J.S., Saper C.B. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc. Natl. Acad. Sci. U.S.A. 95:1998;741-746.
67. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 395:1998;535-547.
68. Elmquist J.K., Elias C.F., Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron. 22:1999;221-232.
69. Emond M., Schwartz G.J., Ladenheim E.E., Moran T.H. Central leptin modulates behavioral and neural responsivity to CCK. Am. J. Physiol. 276:1999;R1545-R1549.
70. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-421.
71. Fan W., Dinulescu D.M., Butler A.A., Zhou J., Marks D.L., Cone R.D. The central melanocortin system can directly regulate serum insulin levels. Endocrinology. 141:2000;3072-3079.
72. Fathi Z., Corjay M.H., Shapira H., Wada E., Benya R., Jensen R.et al. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J. Biol. Chem. 268:1993;5979-5984.
73. Flood J.F., Morley J.E. Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation. Peptides. 10:1989;963-966.
74. Flynn F.W. Effects of fourth ventricle bombesin injection on meal-related parameters and grooming behavior. Peptides. 12:1991;761-765.
75. Flynn F.W., Robillard L. Inhibition of ingestive behavior following fourth ventricle bombesin injection in chronic decerebrate rats. Behav. Neurosci. 106:1992;1011-1014.
76. Forbes S., Bui S., Robinson B.R., Hochgeschwender U., Brennan M.B. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc. Natl. Acad. Sci. U.S.A. 98:2001;4233-4237.
77. Forrest D., Erway L.C., Ng L., Altschuler R., Curran T. Thyroid hormone receptor beta is essential for development of auditory function. Nat. Genet. 13:1996;354-357.
78. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature. 395:1998;763-770.
79. Furuse M., Matsumoto M., Mori R., Sugahara K., Kano K., Hasegawa S. Influence of fasting and neuropeptide Y on the suppressive food intake induced by intracerebroventricular injection of glucagon-like peptide-1 in the neonatal chick. Brain Res. 764:1997;289-292.
80. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J.et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268:1993;15174-15179.
81. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200:1994;1214-1220.
82. Gautvik K.M., de Lecea L., Gautvik V.T., Danielson P.E., Tranque P., Dopazo A.et al. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8733-8738.
83. Gebre-Medhin S., Mulder H., Pekny M., Westermark G., Tornell J., Westermark P.et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem. Biophys. Res. Commun. 250:1998;271-277.
84. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6231-6235.
85. Gibbs J., Falasco J.D., McHugh P.R. Cholecystokinin-decreased food intake in rhesus monkeys. Am. J. Physiol. 230:1976;15-18.
86. Gibbs J., Fauser D.J., Rowe E.A., Rolls B.J., Rolls E.T., Maddison S.P. Bombesin suppresses feeding in rats. Nature. 282:1979;208-210.
87. Gibbs J., Young R.C., Smith G.P. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84:1973;488-495.
88. Goldstone A.P., Morgan I., Mercer J.G., Morgan D.G., Moar K.M., Ghatei M.A.et al. Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA. Biochem. Biophys. Res. Commun. 269:2000;331-335.
89. Graham M., Shutter J.R., Sarmiento U., Sarosi I., Stark K.L. Overexpression of Agrt leads to obesity in transgenic mice. Nat. Genet. 17:1997;273-274.
90. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann. N.Y. Acad. Sci. 697:1993;53-60.
91. Gray T.S., Magnuson D.J. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. J. Comp. Neurol. 262:1987;365-374.
92. Griffon N., Mignon V., Facchinetti P., Diaz J., Schwartz J.C., Sokoloff P. Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200:1994;1007-1014.
93. Grill H.J., Schwartz M.W., Kaplan J.M., Foxhall J.S., Breininger J., Baskin D.G. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology. 143:2002;239-246.
94. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S.et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10911-10916.
95. Hagan M.M. Peptide YY: a key mediator of orexigenic behavior. Peptides. 23:2002;377-382.
96. Hagan M.M., Rushing P.A., Benoit S.C., Woods S.C., Seeley R.J. Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. Am. J. Physiol Regul. Integr. Comp. Physiol. 280:2001;R814-R821.
97. Hagan M.M., Rushing P.A., Pritchard L.M., Schwartz M.W., Strack A.M., Van Der Ploeg L.H.et al. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:2000;R47-R52.
98. Hagan M.M., Rushing P.A., Schwartz M.W., Yagaloff K.A., Burn P., Woods S.C.et al. Role of the CNS melanocortin system in the response to overfeeding. J. Neurosci. 19:1999;2362-2367.
99. Hahn T.M., Breininger J.F., Baskin D.G., Schwartz M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1:1998;271-272.
100. Hampton L.L., Ladenheim E.E., Akeson M., Way J.M., Weber H.C., Sutliff V.E.et al. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3188-3192.
101. Han V.K., Hynes M.A., Jin C., Towle A.C., Lauder J.M., Lund P.K. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J. Neurosci. Res. 16:1986;97-107.
102. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M.et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 30:2001;345-354.
103. Haynes A.C., Jackson B., Overend P., Buckingham R.E., Wilson S., Tadayyon M.et al. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides. 20:1999;1099-1105.
104. Heinrichs S.C., Menzaghi F., Pich E.M., Hauger R.L., Koob G.F. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 611:1993;18-24.
105. Hetherington A.W., Ranson S.W. Hypothalamic lesions and adiposity in the rat. Anat. Rec. 78:1940;149-172.
106. Heuer H., Schafer M.K., O'Donnell D., Walker P., Bauer K. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J. Comp. Neurol. 428:2000;319-336.
107. Holdeman M., Lipton J.M. Antipyretic activity of a potent alpha-MSH analog. Peptides. 6:1985;273-275.
108. Hollopeter G., Erickson J.C., Seeley R.J., Marsch D.J., Palmiter R.D. Response of neuropeptide Y-deficient mice to feeding effectors. Regul. Pept. 75:1998;383-389.
109. Holmes F.E., Mahoney S., King V.R., Bacon A., Kerr N.C., Pachnis V.et al. Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11563-11568.
110. Horvath T.L., Diano S., Sotonyi P., Heiman M., Tschop M. Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology. 142:2001;4163-4169.
111. Horvath T.L., Kalra S.P., Naftolin F., Leranth C. Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus. J. Neuroendocrinol. 7:1995;579-588.
112. Horvath T.L., Naftolin F., Leranth C., Sahu A., Kalra S.P. Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology. 137:1996;3069-3078.
113. Howard A.D., Tan C., Shiao L.L., Palyha O.C., McKee K.K., Weinberg D.H.et al. Molecular cloning and characterization of a new receptor for galanin. FEBS Lett. 405:1997;285-290.
114. Hu Y., Bloomquist B.T., Cornfield L.J., DeCarr L.B., Flores-Riveros J.R., Friedman L.et al. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. 271:1996;26315-26319.
115. Huang Q., Rivest R., Richard D. Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology. 139:1998;1524-1532.
116. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R.et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
117. Iadarola M.J., Naranjo J.R., Duchemin A.M., Quach T.T. Expression of cholecystokinin and enkephalin mRNA in discrete brain regions. Peptides. 10:1989;687-692.
118. Jaszberenyi M., Bujdoso E., Kiss E., Pataki I., Telegdy G. The role of NPY in the mediation of orexin-induced hypothermia. Regul. Pept. 104:2002;55-59.
119. Jezova D., Bartanusz V., Westergren I., Johansson B.B., Rivier J., Vale W.et al. Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology. 130:1992;1024-1029.
120. Johnston S.A., Merali Z. Specific neuroanatomical and neurochemical correlates of locomotor and grooming effects of bombesin. Peptides. 9(Suppl. 1):1988;245-256.
121. 2+ pool and of neuropeptide secretion. Nature. 385:1997;343-346.
122. Jones D.N., Gartlon J., Parker F., Taylor S.G., Routledge C., Hemmati P.et al. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl.). 153:2001;210-218.
123. Jureus A., Cunningham M.J., McClain M.E., Clifton D.K., Steiner R.A. Galanin-like peptide (GALP) is a target for regulation by leptin in the hypothalamus of the rat. Endocrinology. 141:2000;2703-2706.
124. Kaga T., Inui A., Okita M., Asakawa A., Ueno N., Kasuga M.et al. Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding. Diabetes. 50:2001;1206-1210.
125. Kahn S.E., Andrikopoulos S., Verchere C.B. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes. 48:1999;241-253.
126. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:1999;68-100.
127. Kalsbeek A., Fliers E., Romijn J.A., la Fleur S.E., Wortel J., Bakker O.et al. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology. 142:2001;2677-2685.
128. Kalsbeek A., Teclemariam-Mesbah R., Pevet P. Efferent projections of the suprachiasmatic nucleus in the golden hamster (Mesocricetus auratus). J. Comp. Neurol. 332:1993;293-314.
129. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes. 50:2001;2438-2443.
130. Kanatani A., Hata M., Mashiko S., Ishihara A., Okamoto O., Haga Y.et al. A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814. Mol. Pharmacol. 59:2001;501-505.
131. Kapeller R., Moriarty A., Strauss A., Stubdal H., Theriault K., Siebert E.et al. Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin. J. Biol. Chem. 274:1999;24980-24986.
132. Karolyi I.J., Burrows H.L., Ramesh T.M., Nakajima M., Lesh J.S., Seong E.et al. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11595-11600.
133. Kask A., Rago L., Wikberg J.E., Schioth H.B. Differential effects of melanocortin peptides on ingestive behaviour in rats: evidence against the involvement of MC(3) receptor in the regulation of food intake. Neurosci. Lett. 283:2000;1-4.
134. Kastin A.J., Akerstrom V., Pan W. Activation of urocortin transport into brain by leptin. Peptides. 21:2000;1811-1817.
135. Katsuno T., Pradhan T.K., Ryan R.R., Mantey S.A., Hou W., Donohue P.J.et al. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R). Biochemistry. 38:1999;7307-7320.
136. Kerr B.J., Cafferty W.B., Gupta Y.K., Bacon A., Wynick D., McMahon S.B.et al. Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury. Eur. J. Neurosci. 12:2000;793-802.
137. Kesterson R.A., Huszar D., Lynch C.A., Simerly R.B., Cone R.D. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol. Endocrinol. 11:1997;630-637.
138. Kieffer T.J., Habener J.F. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 278:2000;E1-E14.
139. Kim M.S., Small C.J., Stanley S.A., Morgan D.G., Seal L.J., Kong W.M.et al. The central melanocortin system affects the hypothalamo-pituitary-thyroid axis and may mediate the effect of leptin. J. Clin. Invest. 105:2000;1005-1011.
140. Kimura T., Tanizawa O., Mori K., Brownstein M.J., Okayama H. Structure and expression of a human oxytocin receptor. Nature. 356:1992;526-529.
141. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F.et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24:2000;415-419.
142. Kislauskis E., Bullock B., McNeil S., Dobner P.R. The rat gene encoding neurotensin and neuromedin N. Structure, tissue-specific expression, and evolution of exon sequences. J. Biol. Chem. 263:1988;4963-4968.
143. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660.
144. Kolakowski L.F. Jr., Jung B.P., Nguyen T., Johnson M.P., Lynch K.R., Cheng R.et al. Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. 398:1996;253-258.
145. Koritschoner N.P., Alvarez-Dolado M., Kurz S.M., Heikenwalder M.F., Hacker C., Vogel F.et al. Thyroid hormone regulates the obesity gene tub. EMBO Rep. 2:2001;499-504.
146. Kostich W.A., Chen A., Sperle K., Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 12:1998;1077-1085.
147. Kotz C.M., Grace M.K., Briggs J., Levine A.S., Billington C.J. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J. Clin. Invest. 96:1995;163-170.
148. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S.et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 393:1998;72-76.
149. Krysiak R., Obuchowicz E., Herman Z.S. Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. Eur. J. Endocrinol. 140:1999;130-136.
150. Kubo M., Ishizuka T., Kijima H., Kakinuma M., Koike T. Cloning of a mouse adrenocorticotropin receptor-encoding gene. Gene. 153:1995;279-280.
151. Kuhar M.J., Dall Vechia S.E. CART peptides: novel addiction- and feeding-related neuropeptides. Trends Neurosci. 22:1999;316-320.
152. Kulkosky P.J., Breckenridge C., Krinsky R., Woods S.C. Satiety elicited by the C-terminal octapeptide of cholecystokinin-pancreozymin in normal and VMH-lesioned rats. Behav. Biol. 18:1976;227-234.
153. Kunii K., Yamanaka A., Nambu T., Matsuzaki I., Goto K., Sakurai T. Orexins/hypocretins regulate drinking behaviour. Brain Res. 842:1999;256-261.
154. Kyrkouli S.E., Stanley B.G., Seirafi R.D., Leibowitz S.F. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides. 11:1990;995-1001.
155. Lambert P.D., Couceyro P.R., McGirr K.M., Dall Vechia S.E., Smith Y., Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 29:1998;293-298.
156. Larsen P.J., Vrang N., Petersen P.C., Kristensen P. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Obes. Res. 8:2000;590-596.
157. Laurent F.M., Hindelang C., Klein M.J., Stoeckel M.E., Felix J.M. Expression of the oxytocin and vasopressin genes in the rat hypothalamus during development: an in situ hybridization study. Brain Res. Dev. Brain Res. 46:1989;145-154.
158. Legradi G., Lechan R.M. The arcuate nucleus is the major source for neuropeptide Y-innervation of thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology. 139:1998;3262-3270.
159. Levine A.S., Kneip J., Grace M., Morley J.E. Effect of centrally administered neurotensin on multiple feeding paradigms. Pharmacol. Biochem. Behav. 18:1983;19-23.
160. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C.et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7570-7575.
161. Li X.L., Aou S., Hori T., Oomura Y. Spatial memory deficit and emotional abnormality in OLETF rats. Physiol. Behav. 75:2002;15-23.
162. Liao N., Bulant M., Nicolas P., Vaudry H., Pelletier G. Anatomical interactions of proopiomelanocortin (POMC)-related peptides, neuropeptide Y (NPY) and dopamine beta-hydroxylase (D beta H) fibers and thyrotropin-releasing hormone (TRH) neurons in the paraventricular nucleus of rat hypothalamus. Neuropeptides. 18:1991;63-67.
163. Lopez M., Seoane L., Garcia M.C., Lago F., Casanueva F.F., Senaris R.et al. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem. Biophys. Res. Commun. 269:2000;41-45.
164. Lovenberg T.W., Chalmers D.T., Liu C., De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology. 136:1995;4139-4142.
165. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B.et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 92:1995;836-840.
166. Lu Q.H., Swierczek J.S., Zhu X.G., Greeley G.H. Jr., Thompson J.C. Central versus peripheral effects of bombesin on the release of gastrointestinal hormones in dogs. J. Neurosci. Res. 16:1986;553-559.
167. Ludwig D.S., Tritos N.A., Mastaitis J.W., Kulkarni R., Kokkotou E., Elmquist J.et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J. Clin. Invest. 107:2001;379-386.
168. Luttinger D., King R.A., Sheppard D., Strupp J., Nemeroff C.B., Prange A.J. Jr. The effect of neurotensin on food consumption in the rat. Eur. J. Pharmacol. 81:1982;499-503.
169. Lutz T.A., Rossi R., Althaus J., Del Prete E., Scharrer E. Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats. Peptides. 19:1998;1533-1540.
170. Lutz T.A., Tschudy S., Rushing P.A., Scharrer E. Amylin receptors
171. MacLusky N.J., Cook S., Scrocchi L., Shin J., Kim J., Vaccarino F.et al. Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology. 141:2000;752-762.
172. Mantzoros C.S. Leptin and the hypothalamus: neuroendocrine regulation of food intake [news]. Mol. Psychiatry. 4:1999;7-8.
173. Mantzoros C.S. Role of leptin in reproduction. Ann. N.Y. Acad. Sci. 900:2000;174-183.
174. Marks J.L., Porte D. Jr., Stahl W.L., Baskin D.G. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology. 127:1990;3234-3236.
175. Marsh D.J., Hollopeter G., Kafer K.E., Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 4:1998;718-721.
176. Matsumoto Y., Watanabe T., Adachi Y., Itoh T., Ohtaki T., Onda H.et al. Galanin-like peptide stimulates food intake in the rat. Neurosci. Lett. 322:2002;67-69.
177. Mayfield D.K., Brown A.M., Page G.P., Garvey W.T., Shriver M.D., Argyropoulos G. A role for the Agouti-related protein promoter in obesity and type 2 diabetes. Biochem. Biophys. Res. Commun. 287:2001;568-573.
178. Mazella J., Botto J.M., Guillemare E., Coppola T., Sarret P., Vincent J.P. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J. Neurosci. 16:1996;5613-5620.
179. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D.et al. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 273:1998;26273-26276.
180. McDonald T.J., Dupre J., Tatemoto K., Greenberg G.R., Radziuk J., Mutt V. Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes. 34:1985;192-196.
181. McDonald T.J., Jornvall H., Nilsson G., Vagne M., Ghatei M., Bloom S.R.et al. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem. Biophys. Res. Commun. 90:1979;227-233.
182. McMinn J.E., Wilkinson C.W., Havel P.J., Woods S.C., Schwartz M.W. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:2000;R695-R703.
183. Meguid M.M., Fetissov S.O., Varma M., Sato T., Zhang L., Laviano A.et al. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition. 16:2000;843-857.
184. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387:1996;113-116.
185. Mihaly E., Fekete C., Tatro J.B., Liposits Z., Stopa E.G., Lechan R.M. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J. Clin. Endocrinol. Metab. 85:2000;2596-2603.
186. Miltenberger R.J., Mynatt R.L., Wilkinson J.E., Woychik R.P. The role of the agouti gene in the yellow obese syndrome. J. Nutr. 127:1997;1902S-1907S.
187. Miyasaka K., Kanai S., Ohta M., Kawanami T., Kono A., Funakoshi A. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene. Neurosci. Lett. 180:1994;143-146.
188. Mizuno T.M., Kleopoulos S.P., Bergen H.T., Roberts J.L., Priest C.A., Mobbs C.V. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes. 47:1998;294-297.
189. Moller C., Sommer W., Thorsell A., Heilig M. Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology. 21:1999;507-512.
190. Moran T.H. Cholecystokinin and satiety: current perspectives. Nutrition. 16:2000;858-865.
191. Moran T.H., Ameglio P.J., Schwartz G.J., McHugh P.R. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am. J. Physiol. 262:1992;R46-R50.
192. Moran T.H., McHugh P.R. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am. J. Physiol. 242:1982;R491-R497.
193. Moran T.H., Robinson P.H., Goldrich M.S., McHugh P.R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 362:1986;175-179.
194. Mori K., Yoshimoto A., Takaya K., Hosoda K., Ariyasu H., Yahata K.et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett. 486:2000;213-216.
195. Morley J.E. Neuropeptide regulation of appetite and weight. Endocr. Rev. 8:1987;256-287.
196. Morley J.E., Levine A.S. Thyrotropin releasing hormone (TRH) suppresses stress induced eating. Life Sci. 27:1980;269-274.
197. Morley J.E., Levine A.S., Grace M., Kneip J. Peptide YY (PYY), a potent orexigenic agent. Brain Res. 341:1985;200-203.
198. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
199. Muff R., Born W., Fischer J.A. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur. J. Endocrinol. 133:1995;17-20.
200. Muff R., Buhlmann N., Fischer J.A., Born W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology. 140:1999;2924-2927.
201. Muglia L., Jacobson L., Dikkes P., Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature. 373:1995;427-432.
202. Muller M.B., Keck M.E., Zimmermann S., Holsboer F., Wurst W. Disruption of feeding behavior in CRH receptor 1-deficient mice is dependent on glucocorticoids. Neuroreport. 11:2000;1963-1966.
203. Munroe D.G., Gupta A.K., Kooshesh F., Vyas T.B., Rizkalla G., Wang H.et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1569-1573.
204. Myers R.D., Swartzwelder H.S., Peinado J.M., Lee T.F., Hepler J.R., Denbow D.M.et al. CCK and other peptides modulate hypothalamic norepinephrine release in the rat: dependence on hunger or satiety. Brain Res. Bull. 17:1986;583-597.
205. Nagata A., Ito M., Iwata N., Kuno J., Takano H., Minowa O. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11825-11830.
206. Nahon J.L., Presse F., Bittencourt J.C., Sawchenko P.E., Vale W. The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology. 125:1989;2056-2065.
207. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K.et al. A role for ghrelin in the central regulation of feeding. Nature. 409:2001;194-198.
208. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:1999;243-260.
209. Nauck M.A., Niedereichholz U., Ettler R., Holst J.J., Orskov C., Ritzel R.et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am. J. Physiol. 273:1997;E981-E988.
210. Navarro M., Rodriquez D.F., Alvarez E., Chowen J.A., Zueco J.A., Gomez R.et al. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J. Neurochem. 67:1996;1982-1991.
211. Naveilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk A., Chhajlani V.et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat. Med. 5:1999;1188-1193.
212. Nijenhuis W.A., Oosterom J., Adan R.A. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15:2001;164-171.
213. Nijsen M.J., de Ruiter G.J., Kasbergen C.M., Hoogerhout P., De Wildt D.J. Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats. Br. J. Pharmacol. 131:2000;1468-1474.
214. Nishijo H., Uwano T., Tamura R., Ono T. Gustatory and multimodal neuronal responses in the amygdala during licking and discrimination of sensory stimuli in awake rats. J. Neurophysiol. 79:1998;21-36.
215. Nishimori K., Young L.J., Guo Q., Wang Z., Insel T.R., Matzuk M.M. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11699-11704.
216. O'Doherty J., Rolls E.T., Francis S., Bowtell R., McGlone F., Kobal G.et al. Sensory-specific satiety-related olfactory activation of the human orbitofrontal cortex. Neuroreport. 11:2000;893-897.
217. Ohki-Hamazaki H., Sakai Y., Kamata K., Ogura H., Okuyama S., Watase K.et al. Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor. J. Neurosci. 19:1999;948-954.
218. Ohki-Hamazaki H., Watase K., Yamamoto K., Ogura H., Yamano M., Yamada K.et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature. 390:1997;165-169.
219. Ohta M., Kanai S., Sato Y., Masuda M., Takahashi T., Jimi A.et al. Mechanism of delayed gastric emptying in naturally occurring CCK-A receptor gene knockout (OLETF) rats. Jpn. J. Physiol. 50:2000;443-448.
220. Oki Y., Iwabuchi M., Masuzawa M., Watanabe F., Ozawa M., Iino K.et al. Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus. Life Sci. 62:1998;807-812.
221. Oku J., Inoue S., Glick Z., Bray G.A., Walsh J.H. Cholecystokinin, bombesin and neurotensin in brain tissue from obese animals. Int. J. Obes. 8:1984;171-182.
222. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I.et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:1997;135-138.
223. Olson B.R., Drutarosky M.D., Chow M.S., Hruby V.J., Stricker E.M., Verbalis J.G. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides. 12:1991;113-118.
224. Olson B.R., Drutarosky M.D., Stricker E.M., Verbalis J.G. Brain oxytocin receptors mediate corticotropin-releasing hormone-induced anorexia. Am. J. Physiol. 260:1991;R448-R452.
225. Orskov C., Bersani M., Johnsen A.H., Hojrup P., Holst J.J. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J. Biol. Chem. 264:1989;12826-12829.
226. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L.et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145:2001;669-673.
227. Parrott R.F. Central effects of CCK ligands in pigs making operant responses for food. Pharmacol. Biochem. Behav. 49:1994;463-469.
228. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T.et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:1995;540-543.
229. Peruzzo B., Pastor F.E., Blazquez J.L., Schobitz K., Pelaez B., Amat P.et al. A second look at the barriers of the medial basal hypothalamus. Exp. Brain Res. 132:2000;10-26.
230. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G.et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
231. Piper D.C., Upton N., Smith M.I., Hunter A.J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12:2000;726-730.
232. Primus R.J., Yevich E., Baltazar C., Gallager D.W. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology. 17:1997;308-316.
233. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J.et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature. 380:1996;243-247.
234. Rada P., Mark G.P., Hoebel B.G. Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior. Brain Res. 798:1998;1-6.
235. Raikhinstein M., Zohar M., Hanukoglu I. cDNA cloning and sequence analysis of the bovine adrenocorticotropic hormone (ACTH) receptor. Biochim. Biophys. Acta. 1220:1994;329-332.
236. Redei E., Rittenhouse P.A., Revskoy S., McGivern R.F., Aird F. A novel endogenous corticotropin release inhibiting factor. Ann. N.Y. Acad. Sci. 840:1998;456-469.
237. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A.et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98:2001;2843-2848.
238. Robinson L.J., Leitner W., Draznin B., Heidenreich K.A. Evidence that p21ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons. Endocrinology. 135:1994;2568-2573.
239. Rodriguez-Sinovas A., Fernandez E., Manteca X., Fernandez A.G., Gonalons E. CCK is involved in both peripheral and central mechanisms controlling food intake in chickens. Am. J. Physiol. 272:1997;R334-R340.
240. Rogers R.C., Hermann G.E. Oxytocin, oxytocin antagonist, TRH, and hypothalamic paraventricular nucleus stimulation effects on gastric motility. Peptides. 8:1987;505-513.
241. Rokaeus A., Melander T., Hokfelt T., Lundberg J.M., Tatemoto K., Carlquist M.et al. A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci. Lett. 47:1984;161-166.
242. Rossi M., Kim M.S., Morgan D.G., Small C.J., Edwards C.M., Sunter D.et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology. 139:1998;4428-4431.
243. 2+ channels. Neuroendocrinology. 54:1991;559-565.
244. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., D'Alessio D.A., Air E.L.et al. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology. 142:2001;5035.
245. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., Woods S.C. Amylin: a novel action in the brain to reduce body weight. Endocrinology. 141:2000;850-853.
246. Sahu A., Carraway R.E., Wang Y.P. Evidence that neurotensin mediates the central effect of leptin on food intake in rat. Brain Res. 888:2001;343-347.
247. Sahu A., Kalra S.P., Crowley W.R., Kalra P.S. Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res. 457:1988;376-378.
248. Sailer A.W., Sano H., Zeng Z., McDonald T.P., Pan J., Pong S.S.et al. Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7564-7569.
249. Saito Y., Nothacker H.P., Wang Z., Lin S.H., Leslie F., Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature. 400:1999;265-269.
250. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382:1986;213-238.
251. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H.et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior [comment]. Cell. 92:1998;1.
252. Schuit F.C., Huypens P., Heimberg H., Pipeleers D.G. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes. 50:2001;1-11.
253. Schulingkamp R.J., Pagano T.C., Hung D., Raffa R.B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 24:2000;855-872.
254. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Porte D. Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13:1992;387-414.
255. Schwartz M.W., Seeley R.J., Campfield L.A., Burn P., Baskin D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98:1996;1101-1106.
256. Schwartz M.W., Sipols A.J., Marks J.L., Sanacora G., White J.D., Scheurink A.et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 130:1992;3608-3616.
257. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
258. Scrocchi L.A., Brown T.J., MaClusky N., Brubaker P.L., Auerbach A.B., Joyner A.L.et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat. Med. 2:1996;1254-1258.
259. Seeley R.J., Yagaloff K.A., Fisher S.L., Burn P., Thiele T.E., van Dijk G.et al. Melanocortin receptors in leptin effects. Nature. 390:1997;349.
260. Sexton P.M., Paxinos G., Kenney M.A., Wookey P.J., Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience. 62:1994;553-567.
261. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K.et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 50:2001;227-232.
262. Shioda S., Nakai Y. Medullary synaptic inputs to thyrotropin-releasing hormone (TRH)-containing neurons in the hypothalamus: an ultrastructural study combining WGA-HRP anterograde tracing with TRH immunocytochemistry. Brain Res. 625:1993;9-15.
263. Shiraishi T., Oomura Y., Sasaki K., Wayner M.J. Effects of leptin and orexin-A on food intake and feeding related hypothalamic neurons. Physiol. Behav. 71:2000;251-261.
264. Shutter J.R., Graham M., Kinsey A.C., Scully S., Luthy R., Stark K.L. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11:1997;593-602.
265. Small C.J., Kim M.S., Stanley S.A., Mitchell J.R., Murphy K., Morgan D.G.et al. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes. 50:2001;248-254.
266. Spanswick D., Smith M.A., Groppi V.E., Logan S.D., Ashford M.L. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature. 390:1997;521-525.
267. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W.et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564.
268. Spindel E.R., Giladi E., Brehm P., Goodman R.H., Segerson T.P. Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol. Endocrinol. 4:1990;1956-1963.
269. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 7:1986;1189-1192.
270. Stanley B.G., Leibowitz S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. U.S.A. 82:1985;3940-3943.
271. Stanley S.A., Small C.J., Murphy K.G., Rayes E., Abbott C.R., Seal L.J.et al. Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res. 893:2001;186-194.
272. Steiner R.A., Hohmann J.G., Holmes A., Wrenn C.C., Cadd G., Jureus A.et al. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 98:2001;4184-4189.
273. Stenzel-Poore M.P., Cameron V.A., Vaughan J., Sawchenko P.E., Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130:1992;3378-3386.
274. Stubdal H., Lynch C.A., Moriarty A., Fang Q., Chickering T., Deeds J.D.et al. Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutation. Mol. Cell Biol. 20:2000;878-882.
275. Sunter D., Morgan I., Edwards C.M., Dakin C.L., Murphy K.G., Gardiner J.et al. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res. 907:2001;27-34.
276. Suzuki T., Kohno H., Sakurada T., Tadano T., Kisara K. Intracranial injection of thyrotropin releasing hormone (TRH) suppresses starvation-induced feeding and drinking in rats. Pharmacol. Biochem. Behav. 17:1982;249-253.
277. Szekely M., Petervari E., Balasko M., Hernadi I., Uzsoki B. Effects of orexins on energy balance and thermoregulation. Regul. Pept. 104:2002;47-53.
278. Tanaka K., Masu M., Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron. 4:1990;847-854.
279. Tang-Christensen M., Larsen P.J., Thulesen J., Romer J., Vrang N. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat. Med. 6:2000;802-807.
280. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R.et al. Identification and expression cloning of a leptin receptor, Ob-R. Cell. 83:1995;1263-1271.
281. Thiele T.E., van Dijk G., Campfield L.A., Smith F.J., Burn P., Woods S.C.et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am. J. Physiol. 272:1997;R726-R730.
282. Thim L., Kristensen P., Nielsen P.F., Wulff B.S., Clausen J.T. Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2722-2727.
283. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K.et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 [see comments]. Nat. Genet. 19:1998;162-166.
284. Toshinai K., Mondal M.S., Nakazato M., Date Y., Murakami N., Kojima M.et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun. 281:2001;1220-1225.
285. Trivedi P., Yu H., MacNeil D.J., Van Der Ploeg L.H., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438:1998;71-75.
286. Tsai C.H., Hill M., Asa S.L., Brubaker P.L., Drucker D.J. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am. J. Physiol. 273:1997;E77-E84.
287. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature. 407:2000;908-913.
288. Tsujii S., Bray G.A. Acetylation alters the feeding response to MSH and beta-endorphin. Brain Res. Bull. 23:1989;165-169.
289. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K.et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 379:1996;69-72.
290. Uehara Y., Shimizu H., Ohtani K., Sato N., Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes. 47:1998;890-893.
291. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20:1998;113-114.
292. Vaisse C., Halaas J.L., Horvath C.M., Darnell J.E. Jr., Stoffel M., Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14:1996;95-97.
293. Van Bergen P., Janssen P.M., Hoogerhout P., De Wildt D.J., Versteeg D.H. Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship. Eur. J. Pharmacol. 294:1995;795-803.
294. van Dijk G., Seeley R.J., Thiele T.E., Friedman M.I., Ji H., Wilkinson C.W.et al. Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat. Am. J. Physiol. 276:1999;R1425-R1433.
295. van Dijk G., Thiele T.E., Donahey J.C., Campfield L.A., Smith F.J., Burn P.et al. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am. J. Physiol. 271:1996;R1096-R1100.
296. van Dijk G., Thiele T.E., Seeley R.J., Woods S.C., Bernstein I.L. Glucagon-like peptide-1 and satiety. Nature. 385:1997;214.
297. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S.et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
298. Verbalis J.G., Mangione M.P., Stricker E.M. Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology. 128:1991;1317-1322.
299. Vergoni A.V., Bertolini A., Wikberg J.E., Schioth H.B. Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage. Peptides. 20:1999;509-513.
300. Vergoni A.V., Poggioli R., Bertolini A. Corticotropin inhibits food intake in rats. Neuropeptides. 7:1986;153-158.
301. Versteeg D.H., Van Bergen P., Adan R.A., De Wildt D.J. Melanocortins and cardiovascular regulation. Eur. J. Pharmacol. 360:1998;1-14.
302. Vijayan E., McCann S.M. Suppression of feeding and drinking activity in rats following intraventricular injection of thyrotropin releasing hormone (TRH). Endocrinology. 100:1977;1727-1730.
303. Von Schrenck T., Heinz-Erian P., Moran T., Mantey S.A., Gardner J.D., Jensen R.T. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am. J. Physiol. 256:1989;G747-G758.
304. Vrang N., Tang-Christensen M., Larsen P.J., Kristensen P. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res. 818:1999;499-509.
305. Wang C., Billington C.J., Levine A.S., Kotz C.M. Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression. Neuroreport. 11:2000;3251-3255.
306. Wang L., Barachina M.D., Martinez V., Wei J.Y., Tache Y. Synergistic interaction between CCK and leptin to regulate food intake. Regul. Pept. 92:2000;79-85.
307. Wang S., Hashemi T., He C., Strader C., Bayne M. Molecular cloning and pharmacological characterization of a new galanin receptor subtype. Mol. Pharmacol. 52:1997;337-343.
308. Wellman P.J. Norepinephrine and the control of food intake. Nutrition. 16:2000;837-842.
309. Wiegant V.M., Jolles J., Colbern D.L., Zimmermann E., Gispen W.H. Intracerebroventricular ACTH activates the pituitary-adrenal system: dissociation from a behavioral response. Life Sci. 25:1979;1791-1796.
310. Wikstrom L., Johansson C., Salto C., Barlow C., Campos B.A., Baas F.et al. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J. 17:1998;455-461.
311. Wilding J.P., Gilbey S.G., Bailey C.J., Batt R.A., Williams G., Ghatei M.A.et al. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology. 132:1993;1939-1944.
312. Williams G., Cardoso H., Lee Y.C., Ghatei M.A., Flatt P.R., Bailey C.J.et al. Reduced hypothalamic neurotensin concentrations in the genetically obese diabetic (ob/ob) mouse: possible relationship to obesity. Metabolism. 40:1991;1112-1116.
313. Wirth M.M., Giraudo S.Q. Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding. Peptides. 21:2000;1369-1375.
314. Woods S.C., Seeley R.J., Porte D. Jr., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1383.
315. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L., Cohen M.A.et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 50:2001;2540-2547.
316. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S.et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 141:2000;4325-4328.
317. Wynick D., Small C.J., Bacon A., Holmes F.E., Norman M., Ormandy C.J.et al. Galanin regulates prolactin release and lactotroph proliferation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12671-12676.
318. Xu B., Kalra P.S., Farmerie W.G., Kalra S.P. Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology. 140:1999;2868-2875.
319. Yamada M., Konaka S., Satoh T., Monden T., Mori M. Human thyrotropin-releasing hormone-associated peptide 3 (hTAP-3) in serum. Endocr. J. 46:1999;675-679.
320. Yamada M., Saga Y., Shibusawa N., Hirato J., Murakami M., Iwasaki T.et al. Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10862-10867.
321. Yamamoto Y., Ueta Y., Serino R., Nomura M., Shibuya I., Yamashita H. Effects of food restriction on the hypothalamic prepro-orexin gene expression in genetically obese mice. Brain Res. Bull. 51:2000;515-521.
322. Yaswen L., Diehl N., Brennan M.B., Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin [see comments]. Nat. Med. 5:1999;1066-1070.
323. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20:1998;111-112.
324. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
325. Zoeller R.T., Kabeer N., Albers H.E. Cold exposure elevates cellular levels of messenger ribonucleic acid encoding thyrotropin-releasing hormone in paraventricular nucleus despite elevated levels of thyroid hormones. Endocrinology. 127:1990;2955-2962.